PMID- 23595796 OWN - NLM STAT- MEDLINE DCOM- 20131017 LR - 20130418 IS - 1439-3646 (Electronic) IS - 0947-7349 (Linking) VI - 121 IP - 4 DP - 2013 Apr TI - Micro-inflammation characterized by disturbed Treg/Teff balance with increasing sIL-2R in patients with type 2 diabetes. PG - 214-9 LID - 10.1055/s-0033-1333687 [doi] AB - OBJECTIVES: Type 2 diabetes mellitus (T2DM) has been gradually considered as a micro- inflammatory disease. To explore the significance of peripheral CD4(+) regulatory T cells and CD4(+) effector T cells in T2DM, we analyzed inflammation, humoral and cellular immune state in patients with T2DM. PATIENTS AND METHODS: 118 patients with T2DM without complications and 116 healthy volunteers were included. Serum C-reactive protein (CRP), Complement 3 (C3), Complement 4 (C4), IgG, IgA, IgM, plasma sIL-2 R and peripheral T lymphocyte subsets (including CD4(+)CD25(high) regulatory T cells (Treg) and CD4(+)CD25(low+median) effector T cells (Teff)) were analyzed by rate nephelometry immunoassay, chemiluminescence immunoassay and flow cytometry, respectively. RESULTS: (1) micro-inflammation state in T2DM: Serum CRP, C3, IgA and plasma sIL-2 R were all significantly higher in T2DM than those in healthy control (HC) (all P<0.05). (2) Disturbance of cellular immune in T2DM: Compared with HC, the percentage of peripheral CD3(+)CD4(+)T cells and ratio of CD3(+)CD4(+)T cells to CD3(+)CD8(+)T cells in T2DM were both significantly increased (P<0.05); and the percentage of peripheral CD4(+)CD25(+)T cells, Teff cells increased (P>0.05), Treg cells strikingly decreased in T2DM (P<0.05). A positive correlation between sIL-2R levels and peripheral CD4(+)CD25(+)T cells or Teff cell percentages, as well as a negative correlation between plasma sIL-2 R levels and serum HDL, LDL or CHOL levels in T2DM were shown (all P <0.05). CONCLUSIONS: Micro-inflammation state in T2DM was characterized by increased sIL-2 R, elevated CD3(+)CD4(+)T cells and the imbalance of Treg cells and Teff cells, which as one of the pathogeneses took part in inflammation reaction in T2DM. CI - (c) J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart . New York. FAU - Cai, B AU - Cai B AD - Department of Laboratory Medicine, West China Hospital of Sichuan University, Sichuan, PR China. FAU - Zhang, J AU - Zhang J FAU - Zhang, M AU - Zhang M FAU - Li, L AU - Li L FAU - Feng, W AU - Feng W FAU - An, Z AU - An Z FAU - Wang, L AU - Wang L LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130417 PL - Germany TA - Exp Clin Endocrinol Diabetes JT - Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association JID - 9505926 RN - 0 (Complement C3) RN - 0 (Complement C4) RN - 0 (Immunoglobulin A) RN - 0 (Lipids) RN - 0 (Receptors, Interleukin-2) RN - 9007-41-4 (C-Reactive Protein) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - C-Reactive Protein/analysis MH - CD4-Positive T-Lymphocytes/immunology MH - Complement C3/analysis MH - Complement C4/analysis MH - Diabetes Mellitus, Type 2/complications/*immunology MH - Female MH - Humans MH - Immunoglobulin A/blood MH - Inflammation/*complications/*immunology MH - Lipids/blood MH - Lymphocyte Count MH - Male MH - Middle Aged MH - Receptors, Interleukin-2/*blood MH - T-Lymphocyte Subsets/*immunology MH - T-Lymphocytes, Regulatory/*immunology EDAT- 2013/04/19 06:00 MHDA- 2013/10/18 06:00 CRDT- 2013/04/19 06:00 PHST- 2013/04/19 06:00 [entrez] PHST- 2013/04/19 06:00 [pubmed] PHST- 2013/10/18 06:00 [medline] AID - 10.1055/s-0033-1333687 [doi] PST - ppublish SO - Exp Clin Endocrinol Diabetes. 2013 Apr;121(4):214-9. doi: 10.1055/s-0033-1333687. Epub 2013 Apr 17.